HOME >> BIOLOGY >> NEWS
Finding the mind's eye

Dartmouth professor of psychological and brain sciences Peter Tse has published new results in his on-going investigation of the brain and how it transforms visual stimuli into conscious experience. His paper, "Visibility, visual awareness, and visual masking of simple unattended targets are confined to areas in the occipital cortex beyond human V1/V2," is available in the Nov. 8 issue of the weekly journal, The Proceedings of the National Academy of Sciences. Tse's findings help to explain what part of the brain is at work in turning sight into understanding.

Tse, who is currently on sabbatical in Regensburg, Germany as the recipient of the prestigious Friedrich Wilhelm Bessel Research Award, conducted experiments using the phenomenon of "masking." Masking occurs when "a quickly flashed object seems to vanish because it is flanked by subsequently presented objects," said Tse. Using Functional Magnetic Resonance Imaging (fMRI), Tse said he and his team, "looked for areas of the brain where neuronal activity decreased when the object was made invisible. These areas are arguably the areas of the brain where the correlates of visual consciousness lie."

Tse's findings may advance the understanding of the brain's interaction with the eye by identifying the neural basis of conscious experience, a relationship important to the fields of medicine, neurology and psychology.

Tse and his co-authors, Susana Martinez-Conde, Alexander A. Schlegel and Stephen L. Macknik of the Barrow Neurological Institute, found that, "early areas in the visual processing hierarchy respond the same whether or not objects are visible to us or invisible in the context of visual masking." That is, some parts of the brain respond to visual stimuli regardless of whether the conscious mind "sees" them or not. However, Tse and his team found that, "neural activity in areas beyond visual area 2 appear to correlate with perception." They also found that the areas of the brain rel
'"/>

Contact: Genevieve Haas
genevieve.haas@dartmouth.edu
603-646-1445
Dartmouth College
7-Nov-2005


Page: 1 2

Related biology news :

1. Finding protection from tumor growth in unexpected places
2. Finding the white wine difference
3. Finding an answer to Darwins Dilemma
4. Finding a cure for cancer: The holy grail of science
5. Finding the right mix: A biomaterial blend library
6. Finding paves way for better treatment of autoimmune disease
7. Finding about cellular microtubule rigidity could lead to development of new nano-materials
8. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
9. Finding of a new molecular marker of resistance to chemotherapy in breast cancer
10. Finding a cellular Neverland: How stem cells stay childlike
11. Finding a virus is not all bad news

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Finding the mind eye

(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
(Date:7/2/2015)... TN (PRWEB) , ... July 02, 2015 , ... ... the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition ... contract-manufacturing and the world's largest provider of surgical instruments to the Spine Industry. ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)... ... 2015 , ... The next-generation sequencing (NGS) clinical market is poised for huge ... industry. BCC Research reveals in its new report that the market drivers of this ... growing need for better diagnostics as part of a molecular diagnostics trend. , The ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
Cached News: